ABEO earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E 5.00. Updated 2026-07-23.
Abeona Therapeutics (ABEO) Research Hub
Abeona Therapeutics (ABEO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 4.31 USD (-2.05%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 5.00, market cap 0.37B. This hub links to the full technical, earnings and options research available for ABEO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.31 USD (-2.05%) |
| 52-week range | 4.28 USD – 7.65 USD |
| Trend regime | Range |
| 14-day RSI | 30.6 (Bearish) |
| Trailing P/E | 5.00 |
| Market cap | 0.37B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for ABEO
Covered Call on ABEO: how it works, illustrative setup around the real 4.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABEO: how it works, illustrative setup around the real 4.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABEO: how it works, illustrative setup around the real 4.31 USD price, max profit/loss, breakeven and when to use it. Educational.
ABEO technical analysis: range, last 4.31 USD, RSI 30.6, 52w range 4.28 USD–7.65 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ABEO in?
Abeona Therapeutics (ABEO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ABEO in an uptrend or downtrend?
As of 2026-10-26, ABEO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABEO's trailing P/E ratio?
ABEO's trailing P/E is 5.00, with a market cap of 0.37B. See the earnings research page for full valuation detail.
When does ABEO next report earnings?
ABEO is next scheduled to report earnings on 2026-08-13.